PML-RARα and Its Phosphorylation Regulate PML Oligomerization and HIPK2 Stability

被引:16
|
作者
Shima, Yutaka [1 ]
Honma, Yuki [1 ]
Kitabayashi, Issay [1 ]
机构
[1] Natl Canc Ctr, Div Hematol Malignancy, Chuo Ku, Tokyo 1040045, Japan
关键词
ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; RETINOID-X-RECEPTOR; T(15-17) TRANSLOCATION; TRANSCRIPTION FACTORS; NB4; CELLS; ACID; DIFFERENTIATION; DOMAINS; ACTIVATION;
D O I
10.1158/0008-5472.CAN-12-3814
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The PML gene is frequently fused to the retinoic acid receptor alpha (RAR alpha) gene in acute promyelocytic leukemia (APL), generating a characteristic PML-RAR alpha oncogenic chimera. PML-RAR alpha disrupts the discrete nuclear speckles termed nuclear bodies, which are formed in PML, suggesting that nuclear body disruption is involved in leukemogenesis. Nuclear body formation that relies upon PML oligomerization and its stabilization of the hypoxia-inducible protein kinase (HIPK)-2 is disrupted by expression of the PML-RAR alpha chimera. Here, we report that disruption of nuclear bodies is also mediated by PML-RAR alpha inhibition of PML oligomerization. PKAmediated phosphorylation of PML-RAR alpha blocked its ability to inhibit PML oligomerization and destabilize HIPK2. Our results establish that both PML oligomerization and HIPK2 stabilization at nuclear bodies are important for APL cell differentiation, offering insights into the basis for the most common prodifferentiation therapies of APL used clinically. (C) 2013 AACR.
引用
收藏
页码:4278 / 4288
页数:11
相关论文
共 50 条
  • [21] PML-RAR, A FUSION PROTEIN IN ACUTE PROMYELOCYTIC LEUKEMIA
    KAKIZUKA, A
    EVANS, RM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 214 - 214
  • [22] Acute promyelocytic leukemia:: Mechanisms of PML-RARα action
    Reineke, EL
    Liu, H
    Liu, Y
    Kao, HY
    FASEB JOURNAL, 2006, 20 (05): : A966 - A966
  • [23] Relationship between degradation of PML-RARα and differentiation -: Response
    Fanelli, M
    Pelicci, PG
    BLOOD, 1999, 94 (04) : 1479 - 1479
  • [24] Quantitation of PML-RARα transcripts in APL patients -: Response
    Cassinat, B
    Chomienne, C
    LEUKEMIA, 2000, 14 (08) : 1531 - 1531
  • [25] PML Mutation in PML-Rarα Alters PML Nuclear Body Organization and Induces ATRA Resistance in Acute Promyelocytic Leukemia
    Zhu, Hong-Hu
    Wu, Congying
    Sun, Yujie
    Hu, Jiong
    BLOOD, 2018, 132
  • [26] Loss of PML function enhances the frequency and onset of APL in PML-RARα transgenic mice.
    Wang, ZG
    Rego, E
    Peruzzi, D
    He, LZ
    Pandolfi, PP
    BLOOD, 1998, 92 (10) : 479A - 479A
  • [27] The limited contribution of DNA methylation to PML-RARα induced leukemia
    Rohde, Christian
    Schoofs, Till
    Mueller-Tidow, Carsten
    ONCOTARGET, 2013, 4 (01) : 5 - 6
  • [28] EFFECT OF PML AND PML-RAR ON THE TRANSACTIVATION PROPERTIES AND SUBCELLULAR-DISTRIBUTION OF STEROID-HORMONE RECEPTORS
    GUIOCHONMANTEL, A
    SAVOURET, JF
    QUIGNON, F
    DELABRE, K
    MILGROM, E
    DETHE, H
    MOLECULAR ENDOCRINOLOGY, 1995, 9 (12) : 1791 - 1803
  • [29] Arsenic Trioxide Resistance: More to It Than Mutations in PML-RARα
    Abu Alex, Ansu
    Chendamarai, Ezhilarasi
    Ganesan, Saravanan
    Balasundaram, Nithya
    Palani, Hamenth Kumar
    David, Sachin
    Mathews, Vikram
    BLOOD, 2014, 124 (21)
  • [30] Transactivation of the ID2 promoter by the PML-RAR fusion protein.
    Breems-de Ridder, MC
    Erpelinck-Verschueren, CAJ
    van der Reijden, BA
    Lowenberg, B
    Jansen, JH
    BLOOD, 1999, 94 (10) : 258A - 258A